Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doreen Lau

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|March 6, 2021
Feed Restriction Modulates Growth, Gut Morphology and Gene Expression in ZebrafishKathiresan Purushothaman, Jerryl Kim Han Tan, Doreen Lau, et al.
Journal for Immunotherapy of Cancer|August 16, 2023
Reactivation of low avidity tumor-specific CD8<sup>+</sup> T cells associates with immunotherapeutic efficacy of anti-PD-1Gessa Sugiyarto, Doreen Lau, Samuel Luke Hill, et al.
Frontiers in Immunology|August 15, 2020
Intravital Imaging of Adoptive T-Cell Morphology, Mobility and Trafficking Following Immune Checkpoint Inhibition in a Mouse Melanoma ModelDoreen Lau, Fabien Garçon, Anita Chandra, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2022
Imaging PARP with [<sup>18</sup>F]rucaparib in pancreatic cancer modelsChung Ying Chan, Zijun Chen, Gianluca Destro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 28, 2023
[<sup>123</sup>I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of CancerChung Ying Chan, Zijun Chen, Florian Guibbal, et al.
Molecular Pharmaceutics|March 19, 2019
Development and Evaluation of an <sup>18</sup>F-Radiolabeled Monocyclam Derivative for Imaging CXCR4 ExpressionDiana Brickute, Marta Braga, Maciej A Kaliszczak, et al.
EJNMMI Research|August 13, 2022
Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agentClaudia Rose Fraser, Javier Ajenjo, Mathew Veal, et al.
Nuclear Medicine and Biology|June 22, 2020
The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapyLuigi Aloj, Bala Attili, Doreen Lau, et al.
Nature Communications|October 23, 2023
Interferon-γ couples CD8<sup>+</sup> T cell avidity and differentiation during infectionLion F K Uhl, Han Cai, Sophia L Oram, et al.
EJNMMI Research|October 9, 2022
Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [<sup>18</sup>F]olaparib in mouse models of gliomaChung Ying Chan, Samantha L Hopkins, Florian Guibbal, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|March 6, 2021
Feed Restriction Modulates Growth, Gut Morphology and Gene Expression in ZebrafishKathiresan Purushothaman, Jerryl Kim Han Tan, Doreen Lau, et al.
Journal for Immunotherapy of Cancer|August 16, 2023
Reactivation of low avidity tumor-specific CD8<sup>+</sup> T cells associates with immunotherapeutic efficacy of anti-PD-1Gessa Sugiyarto, Doreen Lau, Samuel Luke Hill, et al.
Frontiers in Immunology|August 15, 2020
Intravital Imaging of Adoptive T-Cell Morphology, Mobility and Trafficking Following Immune Checkpoint Inhibition in a Mouse Melanoma ModelDoreen Lau, Fabien Garçon, Anita Chandra, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2022
Imaging PARP with [<sup>18</sup>F]rucaparib in pancreatic cancer modelsChung Ying Chan, Zijun Chen, Gianluca Destro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 28, 2023
[<sup>123</sup>I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of CancerChung Ying Chan, Zijun Chen, Florian Guibbal, et al.
Molecular Pharmaceutics|March 19, 2019
Development and Evaluation of an <sup>18</sup>F-Radiolabeled Monocyclam Derivative for Imaging CXCR4 ExpressionDiana Brickute, Marta Braga, Maciej A Kaliszczak, et al.
EJNMMI Research|August 13, 2022
Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agentClaudia Rose Fraser, Javier Ajenjo, Mathew Veal, et al.
Nuclear Medicine and Biology|June 22, 2020
The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapyLuigi Aloj, Bala Attili, Doreen Lau, et al.
Nature Communications|October 23, 2023
Interferon-γ couples CD8<sup>+</sup> T cell avidity and differentiation during infectionLion F K Uhl, Han Cai, Sophia L Oram, et al.
EJNMMI Research|October 9, 2022
Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [<sup>18</sup>F]olaparib in mouse models of gliomaChung Ying Chan, Samantha L Hopkins, Florian Guibbal, et al.
Pageof 3